Delivery Order SPE2DB22D2206-SPE2DB24FJH12

Award Date 7/19/24
Potential Completion Date 8/9/24
Potential Value $72K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $115,417.92 firm-fixed-price contract is for the supply of GAMUNEX-C 40 gram/400 mL vials, a specialized immunoglobulin medication. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product, with a ceiling value of $55,852.80 and a period of performance running through February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 ml vials. The $2,614.10 firm fixed-price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical on August 11, 2022, with a completion date of September 1, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a specialty medication. The contract has an ultimate completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,648.20, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The contract is a firm fixed price type with a period of performance through December 19, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The award, valued at $4,809.08, is a firm fixed-price contract with a completion date of August 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.46 firm fixed-price contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, with a completion date of December 30, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $14,427.24 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 40 gram/400 ml vials of the medication GAMUNEX-C. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 20 gram/200 ml vials. The $44,366.76 fixed-price contract has a period of performance through December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,011.40 delivery order is for the medical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of October 16, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJH12
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $71,915.80 delivery order is for the supply of GAMUNEX-C 40 gram/400 ML vials, a specialty medication. The order has an ultimate completion date of August 9, 2024. The primary IDC, valued at up to $999,999,999, enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation.

Generated 10/18/24, 9:14 AM